• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,226.10 610.96
(1.18%)
Dow Jones
7,460.10 122.95
(1.68%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,886.26 -22.15
(-0.20%)
Forex
USD-INR
95.69 -0.03
(-0.03%)
EUR-INR
109.15 0.26
(0.24%)
GBP-INR
127.35 0.13
(0.10%)
JPY-INR
0.58 0.00
(0.09%)

EQUITY - MARKET SCREENER

Procter & Gamble Health Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500126
INE199A01012
316.0053682
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PGHL
33.02
10793.75
EPS(TTM)
Face Value()
Div & Yield %
196.94
10
6.38
 

Huhtamaki India standalone net profit rises 159.20% in the December 2025 quarter
Feb 13,2026
Net profit of Huhtamaki India rose 159.20% to Rs 30.30 crore in the quarter ended December 2025 as against Rs 11.69 crore during the previous quarter ended December 2024. Sales declined 0.35% to Rs 599.13 crore in the quarter ended December 2025 as against Rs 601.23 crore during the previous quarter ended December 2024.

For the full year,net profit rose 34.32% to Rs 118.16 crore in the year ended December 2025 as against Rs 87.97 crore during the previous year ended December 2024. Sales declined 2.51% to Rs 2389.04 crore in the year ended December 2025 as against Rs 2450.53 crore during the previous year ended December 2024.

ParticularsQuarter EndedYear Ended
Dec. 2025Dec. 2024% Var.Dec. 2025Dec. 2024% Var.
Sales599.13601.23 0 2389.042450.53 -3
OPM %9.024.36 -7.994.79 -
PBDT54.5629.05 88 209.48133.45 57
PBT40.9815.23 169 157.3285.97 83
NP30.3011.69 159 118.1687.97 34